American Journal of Ophthalmology
Volume 150, Issue 1 , Pages 74-81 , July 2010

The Increased Cost of Medical Services for People Diagnosed With Primary Open-Angle Glaucoma: A Decision Analytic Approach

  • Steven M. Kymes

      Affiliations

    • Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri
    • Center for Health Policy, Washington University School of Medicine, St. Louis, Missouri
    • Corresponding Author InformationInquiries to Steven M. Kymes, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 South Euclid, Campus Box 8096, St. Louis, MO 63110-1093
    • ,
  • Michael R. Plotzke

      Affiliations

    • Division of Economics, Washington University School of Medicine, St. Louis, Missouri
    • Abt Associates, Inc, Cambridge, Massachusetts
    • ,
  • Jim Z. Li

      Affiliations

    • Global Outcomes Research, Pfizer, Inc, San Diego, California
    • ,
  • Michael B. Nichol

      Affiliations

    • Pharmaceutical Economics and Policy, University of Southern California School of Pharmacy, Los Angeles, California
    • ,
  • Joanne Wu

      Affiliations

    • Pharmaceutical Economics and Policy, University of Southern California School of Pharmacy, Los Angeles, California
    • ,
  • Joel Fain

      Affiliations

    • Global Outcomes Research, Pfizer, Inc, San Diego, California

References 

  1. Congdon N, O'Colmain B, Klaver CC, et al. Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485
  2. Friedman DS, Congdon N, Kempen J, Tielsch JM. Vision Problems in the United States. Washington, DC: National Eye Institute; 2002;
  3. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325:1412–1417
  4. Robin AL, Frick KD, Katz J, Budenz D, Tielsch JM. The Ocular Hypertension Treatment Study: intraocular pressure lowering prevents the development of glaucoma, but does that mean we should treat before the onset of disease?. Arch Ophthalmol. 2004;122:376–378
  5. Rice DP. Cost of illness studies: what is good about them?. Inj Prev. 2000;6:177–179
  6. Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries' costs are greater for those with progressive vision loss. Ophthalmology. 2007;114:238–245
  7. Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol. 2007;125:544–550
  8. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754–1760erratum appears in Arch Ophthalmol 2007;125:1304
  9. Lee PP, Levin LA, Walt JG, et al. Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data. Ophthalmology. 2007;114:1241–1247
  10. Gieser DK, Tracy Williams R, O'Connell W, et al. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study. J Glaucoma. 2006;15:419–425
  11. Iskedjian M, Walker J, Vicente C, et al. Cost of glaucoma in Canada: analyses based on visual field and physician's assessment. J Glaucoma. 2003;12:456–462
  12. Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006;124:12–19
  13. Neymark N, Buchholz P, Honrubia F, Kobelt G. The costs of treating glaucoma with combinations of topical drugs in Spain. Eur J Ophthalmol. 2008;18:52–59
  14. Employer Health Benefits: 2007 Annual Survey. Washington, DC: Henry J. Kaiser Family Foundation and Health Research and Education Trust; 2008;http://www.kff.org/insurance/7672/upload/76723.pdfAccessed May 28, 2009
  15. Beals J, Welty TK, Mitchell CM, et al. Different factor loadings for SF36: the Strong Heart Study and the National Survey of Functional Health Status. J Clin Epidemiol. 2006;59:208–215
  16. Wang JJ, Mitchell P, Cumming RG, Smith W, Blue Mountains Eye S. Visual impairment and nursing home placement in older Australians: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2003;10:3–13
  17. Charlson ME, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–1251
  18. Hunt S, Maerki S, Tompkins R. Comparing CPT codes payments for Medi-Cal and other California payers: California Healthcare Foundation, 2001. http://www.chcf.org/topics/medi-cal/index.cfm?itemID=20413Accessed June 17, 2008
  19. Weinstein MC. Recent developments in decision-analytic modeling for economic evaluation. Pharmacoeconomics. 2006;24:1043–1053
  20. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108:1893–1901
  21. Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–244
  22. Koch JM, Datta G, Makhdoom S, Grossberg GT. Unmet visual needs of Alzheimer's disease patients in long-term care facilities. J Am Med Dir Assoc. 2005;6:233–237
  23. Ivers RQ, Mitchell P, Cumming RG. Visual function tests, eye disease and symptoms of visual disability: a population-based assessment. Clin Exper Ophthalmol. 2000;28:41–47
  24. Coleman AL, Stone K, Ewing SK, et al. Higher risk of multiple falls among elderly women who lose visual acuity. Ophthalmology. 2004;111:857–862
  25. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making. 1983;3:419–458
  26. Akbari M, Akbari S, Pasquale LR. The association of primary open-angle glaucoma with mortality: a meta-analysis of observational studies. Arch Ophthalmol. 2009;127:204–210
  27. Willet JB, Singer JD. Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence. J Consult Clin Psychol. 1993;61:952–965
  28. Bramley T, Peeples P, Walt JG, Juhasz M, Hansen JE. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol. 2008;126:849–856
  29. Drummond MF, Schulpher MJ, Torrance GW, O'Brien B, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed.. Oxford: Oxford University Press; 2005;
  30. Goldberg I, Clement CI, Chiang TH, et al. Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire. J Glaucoma. 2009;18:6–12
  31. Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. J Glaucoma. 2008;17:546–551
  32. Varma R, Wu J, Chong K, Azen SP, Hays RD Los Angeles Latino Eye Study G. Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology. 2006;113:1846–1853

PII: S0002-9394(10)00079-6

doi: 10.1016/j.ajo.2010.01.037

American Journal of Ophthalmology
Volume 150, Issue 1 , Pages 74-81 , July 2010

Article Tools

* Image Usage & Resolution